Organizes

SLAMS

Latin American Society for Sexual Medicine

ISSM
en
English
es
Español
pt
Português
Papers submission

Rules for the submission of abstracts to the IX Congress of the Latin American Society for Sexual Medicine - SLAMS

Abstracts can only be submitted through the website www.slams2007.org

Deadline for the submission: September 30, 2007

  1. Abstracts can only be submitted through the website www.slams2007.org. The best accepted abstracts will be awarded.  
  2. Abstracts must be in English, Spanish or Portuguese, and are subject to approval of the Scientific Committee.
  3. Abstracts submitted must be related to Sexual Medicine and to Sexual Dysfunctions.
  4. Abstracts must not have been previously published or submitted to other international scientific meetings.
  5. Abstract structure:
    -Introduction / Objective
    -Materials and Methods
    -Results
    -Conclusions
    Abstracts must adequately describe the objectives and results so that they can be evaluated by the Congress Scientific Committee.
    Use standard abbreviations.
    Abstracts where results are not stated will not be accepted.
  6. Accepted abstracts in English, Spanish or Portuguese will be published in the Congress Abstract Book.
  7. Abstracts will appear exactly as submitted, therefore it is suggested to avoid errors and misspellings.
  8. Corrections to the abstracts already submitted to SLAIS will not be accepted.
  9. Accepted abstracts, in English, will be published in a supplement of "The Journal of Sexual Medicine (JSM)". Authors of accepted abstracts in Spanish or Portuguese, interested in having their abstract published in a supplement of "The Journal of Sexual Medicine" (JSM), must submit the abstract in English within 15 days of receipt of the notification of acceptance. All accepted abstracts in English will be reviewed by an appointed idiomatic committee. If the text does not meet the standards of an international publication as The Journal of Sexual Medicine we will correct the text and will then send it to the responsible author who must confirm his acceptance to the changes made, by e-mail, within 48 hs. If this requirements are not fulfilled the abstract in English will not be sent to The Journal of Sexual Medicine for publication.
  10. Abstracts sent by e-mail, regular mail or fax will not be accepted.
  11. At least one of the authors of an accepted paper must be registered to the Congress. If not, and without exceptions, the abstract will not be published.
  12. All required fields in the abstract form must be completed (e.g. title, authors, contact e-mail, etc.)
  13. Do not use abbreviations in the abstract title.
  14. The title, names or institutions should not be mentioned within the body of the abstract in order to ensure a blind review process by the Scientific Committee.
  15. Maximun length of the text is 2000 characters, including spaces (aproximately 300 words)
  16. The Scientific Committee may modify the type of presentation indicated by the authors (oral, moderated poster, unmoderated poster) according to room availability and scientific quality.
  17. Authors of submitted papers will receive a confirmation that the abstract was received. Presenting authors will be notified of acceptance of their abstract with type of presentation before October 15, 2007. Authors of accepted abstracts must comply with requirement number 11.
  18. Abstracts that do not comply with these rules will not be accepted.
  19. For questions related to this Abstracts Guidelines please contact with info@slams2007.org.

Instructions for completing the abstract form:

Technical support: slams2007@auxsoft.com

  • Go to the web page www.slams2007.org. Click on the "Paper submission" menu. There you will find a link to the abstract form.
  • We suggest that you prepare your abstract beforehand in your computer.
  • If you prepare the abstract with a word processor, don't use formatting options, bulleted lists or images. The form only accepts plain text.
  • An option for adding a simple table is provided by the system. The maximum size of the table is 10 columns by 7 rows.
  • There are separate fields for the title, authors and institutions; do not repeat this information in the body of the abstract.
  • The body of the abstract is limited to 2000 characters (approximately 300 words).
  • Use uppercase and lowercase letters as appropriate: do not write in all uppercase letters.
  • Before submitting your abstract, you will see a "preview" were you can check for errors. The abstract should appear as the following sample:

Use of Ambicor penile prosthesis in Peyronie’s Disease and as replacement for malfunctioning AMS 700 device
Giulio Scarzella, I(1); Steven Wilson, K(2)
(1)George Washington University. (2)University of Arkansas.
Objective: Since introduction in 1996, we have used the Ambicor 2 piece prosthesis as our exclusive inflatable implant in a variety of clinical situations. This retrospective study evaluates device satisfaction, mechanical reliability and medical problems.
Material and Methods: The Ambicor 2 piece inflatable prosthesis was used in 77 consecutive patients presenting for impotence refractory to conservative therapy. We had previously performed 444 3 piece prostheses and the newly available device was offered to all patients regardless of etiology of impotence. Thirty-two were primary implants of which 20 had bothersome Peyronie’s Disease. The remaining 34 were replacement devices for a malfunctioning AMS 700. All implantations received peri-operative antibiotics, closed suction drainage and 4 weeks of post-operative antibiotics. Patients were followed 6 months - 6 years (average 3.5 years.)
Results: All patients are currently implanted with the device. All patients were queried regarding erection and flaccidity satisfaction. Most (95%) were satisfied or very satisfied. Four (12%) of the 34 revision patients were disappointed with girth when compared to their previous 3-piece but none to the extent of requesting revision surgery. All Peyronie’s patients had satisfactory straightening without further adjunctive procedures. There were no infections and 3 mechanical failures. Kaplan Meier statistical study shows 90% three-year survival from revision for mechanical reason.
Conclusions: The Ambicor 2-piece inflatable penile prosthesis has good patient satisfaction even when implanted for Peyronie’s Disease and patients who had previously had 3-piece devices. Mechanical reliability is similar to other inflatable devices and infections did not occur.